| Literature DB >> 17156478 |
Alison M Elliott1, Philip C Hannaford, Blair H Smith, Sally Wyke, Kate Hunt.
Abstract
BACKGROUND: Associations between symptom experience and mortality have rarely been investigated. One study has suggested that the number of symptoms people experience may be an important predictor of mortality. This novel and potentially important finding may have important implications but needs to be tested in other cohorts.Entities:
Mesh:
Year: 2006 PMID: 17156478 PMCID: PMC1702541 DOI: 10.1186/1472-6963-6-158
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
List of 33 symptoms inquired about as part of the West of Scotland Twenty-07 study*
| Colds or flu |
| Persistent cough |
| Palpitations or breathlessness |
| Sinus, catarrh or blocked nose |
| Sore throat |
| Wheezy chest |
| Sore or stiff back |
| Stiff or painful joints |
| Muscle tightness or tension |
| Constipation |
| Stomach pain or cramps |
| Diarrhoea |
| Indigestion |
| Poor appetite |
| Sickness or nausea |
| Piles or haemorrhoids |
| Difficulty sleeping |
| Nerves or tension |
| Difficulty concentrating |
| Worrying over every little thing |
| Feeling depressed |
| Headaches |
| Trembling hands |
| Fainting or dizziness |
| Feeling generally run down |
| Always feeling tired |
| Hot and sweating a lot |
| Cold sweats |
| Trouble with ears |
| Trouble with eyes |
| Skin rash or skin problems |
| Trouble with teeth or mouth |
| Kidney or bladder problems |
*Symptoms were not presented to participants in this order or in these groupings
Hazard ratios for thirteen-year all cause mortality by gender, socio-economic factors and smoking
| Male | 399 | 97 (24.3) | 1.00 |
| Female | 459 | 73 (15.9) | 0.63 (0.47 to 0.86) |
| Non manual | 361 | 51 (14.1) | 1.00 |
| Manual | 497 | 119 (23.9) | 1.80 (1.29 to 2.49) |
| Owned/mortgaged | 474 | 62 (13.1) | 1.00 |
| Rented from council/housing association | 352 | 100 (28.4) | 2.35 (1.71 to 3.23) |
| Private rented and other | 31 | 7 (22.6) | 1.90 (0.87 to 4.15) |
| No | 319 | 88 (27.6) | 1.00 |
| Yes | 538 | 81 (15.1) | 0.51 (0.38 to 0.69) |
| 1+2 | 135 | 17 (12.6) | 1.00 |
| 3–5 | 407 | 72 (17.7) | 1.43 (0.84 to 2.42) |
| 6+7 | 314 | 81 (25.8) | 2.17 (1.29 to 3.66) |
| Never | 285 | 29 (10.2) | 1.00 |
| Ex | 239 | 42 (17.6) | 1.80 (1.12 to 2.89) |
| Current | 334 | 99 (29.6) | 3.24 (2.14 to 4.90) |
Hazard ratios for thirteen-year all cause mortality by chronic conditions and self-assessed health
| No | 439 | 90 (20.5) | 1.00 |
| Yes | 419 | 80 (19.1) | 0.91 (0.67 to 1.23) |
| No | 705 | 128 (18.2) | 1.00 |
| Yes | 153 | 42 (27.5) | 1.59 (1.12 to 2.25) |
| No | 683 | 129 (18.9) | 1.00 |
| Yes | 175 | 41 (23.4) | 1.32 (0.93 to 1.87) |
| No | 627 | 95 (15.2) | 1.00 |
| Yes | 231 | 75 (32.5) | 2.45 (1.81 to 3.33) |
| No | 730 | 138 (18.9) | 1.00 |
| Yes | 128 | 32 (25.0) | 1.37 (0.93 to 2.01) |
| 0 | 107 | 11 (10.3) | 1.00 |
| 1 | 211 | 23 (10.9) | 1.07 (0.52 to 2.20) |
| 2 | 222 | 48 (21.6) | 2.18 (1.13 to 4.20) |
| 3 | 147 | 33 (22.4) | 2.33 (1.18 to 4.61) |
| ≥ 4 | 171 | 55 (32.2) | 3.69 (1.93 to 7.05) |
| Excellent | 118 | 8 (6.8) | 1.00 |
| Good | 398 | 53 (13.3) | 2.01 (0.95 to 4.22) |
| Fair | 238 | 66 (27.7) | 4.55 (2.18 to 9.47) |
| Poor | 103 | 42 (40.8) | 7.72 (3.62 to 16.44) |
Hazard ratios for thirteen-year all cause mortality by type of symptom
| Does not have symptoms | 424 | 66 (15.6) | 1.00 | 1.00 | 1.00 | 1.00 |
| Has symptoms | 434 | 104 (24.0) | 1.60 (1.17 to 2.17) | 1.44 (1.06 to 1.97) | 1.24 (0.89 to 1.71) | 1.10 (0.79 to 1.54) |
| Does not have symptoms | 418 | 78 (18.7) | 1.00 | 1.00 | 1.00 | 1.00 |
| Has symptoms | 440 | 92 (20.9) | 1.12 (0.83 to 1.51) | 1.14 (0.84 to 1.55) | 1.15 (0.84 to 1.56) | 0.99 (0.72 to 1.35) |
| Does not have symptoms | 552 | 101 (18.3) | 1.00 | 1.00 | 1.00 | 1.00 |
| Has symptoms | 306 | 69 (22.5) | 1.29 (0.95 to 1.76) | 1.31 (0.96 to 1.78) | 1.30 (0.95 to 1.77) | 1.13 (0.82 to 1.56) |
| Does not have symptoms | 461 | 70 (15.2) | 1.00 | 1.00 | 1.00 | 1.00 |
| Has symptoms | 397 | 100 (25.2) | 1.78 (1.31 to 2.41) | 1.79 (1.31 to 2.45) | 1.66 (1.21 to 2.28) | 1.42 (1.02 to 1.97) |
| Does not have symptoms | 581 | 112 (19.3) | 1.00 | 1.00 | 1.00 | 1.00 |
| Has symptoms | 277 | 58 (20.9) | 1.11 (0.81 to 1.53) | 1.08 (0.78 to 1.49) | 0.99 (0.71 to 1.37) | 0.81 (0.58 to 1.13) |
| Does not have symptoms | 553 | 92 (16.6) | 1.00 | 1.00 | 1.00 | 1.00 |
| Has symptoms | 305 | 78 (25.6) | 1.63 (1.21 to 2.21) | 1.50 (1.10 to 2.05) | 1.28 (0.93 to 1.76) | 1.00 (0.71 to 1.41) |
* Numbers in each of the five symptom categories add to 858 the total number in the cohort. Numbers given are relevant for unadjusted hazard ratios. Numbers in the sample for each of the adjusted analyses varies only slightly since there was little missing data for the factors we have adjusted for (as can be seen from tables 1 and 2).
1 Adjusted for gender, housing tenure and smoking status
2 Adjusted for gender, housing tenure, smoking status and the presence of a respiratory or cardiovascular condition
3 Adjusted for gender, housing tenure, smoking status, the presence of a respiratory or cardiovascular condition and the number of symptoms present in the last month
Figure 1Distribution of total number of symptoms experienced in the last month based on self report from a list of 33 symptoms.
Hazard ratios for thirteen-year all cause mortality by number of symptoms in five symptom categories
| 87 | 9 (10.3) | 1.00 | 1.00 | 1.00 | 1.00 | ||
| 116 | 16 (13.8) | 1.32 (0.58 to 2.99) | 1.40 (0.62 to 3.17) | 1.21 (0.53 to 2.75) | 1.24 (0.54 to 2.82) | ||
| 128 | 27 (21.1) | 2.13 (1.00 to 4.54) | 2.06 (0.96 to 4.41) | 1.94 (0.90 to 4.15) | 1.99 (0.93 to 4.29) | ||
| 309 | 60 (19.4) | 1.99 (0.99 to 4.00) | 1.99 (0.98 to 4.03) | 1.74 (0.85 to 3.55) | 1.40 (0.68 to 2.86) | ||
| 218 | 58 (26.6) | 2.76 (1.37 to 5.58) | 2.53 (1.24 to 5.16) | 2.03 (0.99 to 4.19) | 1.38 (0.65 to 2.89) | ||
| 120 | 15 (12.5) | 1.00 | 1.00 | 1.00 | 1.00 | ||
| 141 | 18 (12.8) | 0.99 (0.50 to 1.97) | 1.06 (0.53 to 2.10) | 1.00 (0.50 to 1.99) | 0.99 (0.50 to 1.97) | ||
| 138 | 28 (20.3) | 1.68 (0.90 to 3.15) | 1.66 (0.88 to 3.13) | 1.62 (0.86 to 3.05) | 1.51 (0.80 to 2.86) | ||
| 291 | 59 (20.3) | 1.70 (0.96 to 2.99) | 1.60 (0.90 to 2.80) | 1.44 (0.81 to 2.56) | 1.14 (0.64 to 2.06) | ||
| 168 | 50 (29.8) | 2.56 (1.44 to 4.57) | 2.23 (1.24 to 4.02) | 1.85 (1.01 to 3.37) | 1.15 (0.61 to 2.18) | ||
| 588 | 123 (20.9) | 1.00 | 1.00 | 1.00 | 1.00 | ||
| 156 | 29 (18.6) | 0.85 (0.57 to 1.28) | 0.90 (0.60 to 1.36) | 0.93 (0.61 to 1.40) | 0.98 (0.65 to 1.49) | ||
| 59 | 11 (18.6) | 0.89 (0.48 to 1.64) | 1.18 (0.63 to 2.20) | 1.20 (0.64 to 2.25) | 1.16 (0.62 to 2.18) | ||
| 55 | 7 (12.7) | 0.61 (0.28 to 1.30) | 0.71 (0.33 to 1.53) | 0.67 (0.31 to 1.44) | 0.72 (0.33 to 1.55) | ||
| 526 | 84 (16.0) | 1.00 | 1.00 | 1.00 | 1.00 | ||
| 130 | 30 (23.1) | 1.50 (0.99 to 2.28) | 1.45 (0.95 to 2.21) | 1.40 (0.92 to 2.14) | 1.19 (0.77 to 1.82) | ||
| 66 | 18 (27.3) | 1.74 (1.03 to 2.93) | 1.54 (0.90 to 2.61) | 1.41 (0.82 to 2.41) | 1.05 (0.60 to 1.83) | ||
| 97 | 22 (22.7) | 1.54 (0.96 to 2.46) | 1.35 (0.84 to 2.18) | 1.17 (0.72 to 1.90) | 0.85 (0.51 to 1.40) | ||
| 39 | 16 (41.0) | 3.21 (1.88 to 5.49) | 2.42 (1.39 to 4.20) | 1.72 (0.97 to 3.06) | 1.21 (0.67 to 2.21) | ||
| 457 | 72 (15.8) | 1.00 | 1.00 | 1.00 | 1.00 | ||
| 166 | 39 (23.5) | 1.55 (1.05 to 2.29) | 1.49 (1.00 to 2.21) | 1.48 (0.99 to 2.20) | 1.38 (0.93 to 2.06) | ||
| 91 | 19 (20.9) | 1.39 (0.84 to 2.31) | 1.46 (0.88 to 2.43) | 1.36 (0.82 to 2.27) | 1.13 (0.67 to 1.91) | ||
| 96 | 24 (25.0) | 1.63 (1.02 to 2.61) | 1.51 (0.94 to 2.43) | 1.34 (0.83 to 2.16) | 1.08 (0.66 to 1.75) | ||
| 48 | 16 (33.3) | 2.51 (1.46 to 4.31) | 1.96 (1.13 to 3.41) | 1.58 (0.91 to 2.77) | 1.13 (0.63 to 2.01) |
* Numbers in each of the five symptom categories add to 858 the total number in the cohort. Numbers given are relevant for unadjusted hazard ratios. Numbers in the sample for each of the adjusted analyses varies only slightly since there was little missing data for the factors we have adjusted for (as can be seen from tables 1 and 2).
1 Adjusted for gender, housing tenure and smoking status
2 Adjusted for gender, housing tenure, smoking status and the presence of a respiratory or cardiovascular condition
3 Adjusted for gender, housing tenure, smoking status, the presence of a respiratory or cardiovascular condition and self-assessed health